# Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

> **NCT03462459** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 79 (actual)

## Conditions studied

- Recurrent Clostridium Difficile Infection
- Clostridium Difficile Infection
- CDI
- C.Difficile Diarrhea
- C. Diff Colitis
- C.Difficile Colitis

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03462459
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-21
- **Primary completion:** 2023-07-06
- **Final completion:** 2023-07-06
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462459, "Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03462459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*